High frequency of circulating non-classical monocytes is associated with stable remission in relapsing-remitting multiple sclerosis
Open Access
- 27 March 2024
- journal article
- research article
- Published by Taylor & Francis in Immunological Medicine
- Vol. 47 (3) , 151-165
Abstract
1. Multiple sclerosis (MS) is an autoimmune demyelinating disease of the CNS, of which pathogenesis would involve a wide variety of innate and acquired immune cells, including self-reactive T cells...Keywords
Funding Information
- Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development, AMED (JP18ek0109342)
This publication has 49 references indexed in Scilit:
- Multiple sclerosis: Neuroimmune crosstalk and therapeutic targetingCell, 2023
- Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 yearsNeurological Sciences, 2021
- IFN-β and multiple sclerosis: Cross-talking of immune cells and integration of immunoregulatory networksCytokine & Growth Factor Reviews, 2015
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis CohortJAMA Neurology, 2015
- Molecular control of monocyte developmentCellular Immunology, 2014
- Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosisAnnals of Neurology, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritisArthritis & Rheumatism, 2002
- Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelinationAnnals of Neurology, 2000